Skip to content

Clinical trials

Phase 4 Prostatic Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 4 Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20072
20081
20131
20162
20181
20211
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Ottawa Hospital Research Institute2
University Health Network, Toronto2
Guerbet1
Hamilton Health Sciences Corporation1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Novartis Pharmaceuticals1
Ottawa Heart Institute Research Corporation1
RECORDATI GROUP1
Sunnybrook Health Sciences Centre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms13
Breast Neoplasms3
Neoplasm Metastasis2
Neuroendocrine Tumors2
Acromegaly1
Anxiety Disorders1
Carcinoma, Hepatocellular1
Colorectal Neoplasms1
Coronary Artery Disease1
Dumping Syndrome1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.